Wenbin Jiang, Ph.D.

Wenbin Jiang, Ph.D.

Chief Executive Officer and PresidentatCytek Biosciences· In proxies 2021–2025

Pay in FY2025-16% from the year before · Cytek Biosciences stock -22.2% the same year

Wenbin Jiang, Ph.D. was paid $5.1M in FY2025 (Dec), down 16%. Cytek Biosciences stock fell 22.2% that year.

Pay$100 in the stock at the end of FY21 → $31
Pay is from the Summary Compensation Table of each Cytek Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Cytek BiosciencesPublic company · 5 yr
    • Chief Executive Officer and President2021 – Present · 5 yrStock in role -67%
  2. UC Santa BarbaraPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?